GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Horizon Therapeutics PLC (BSP:H1ZN34) » Definitions » Net Investment Income

Horizon Therapeutics (BSP:H1ZN34) Net Investment Income


View and export this data going back to 2020. Start your Free Trial

What is Horizon Therapeutics Net Investment Income?

Net Investment Income only applies to insurance companies.


Horizon Therapeutics (BSP:H1ZN34) Business Description

Traded in Other Exchanges
N/A
Address
70 St. Stephen’s Green, Dublin, IRL, D02 E2X4
Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.